Management and board of directors

General Manager of Vistor

Arnar Þórðarson

General Manager of Vistor

Mr. Þórðarson started as General Manager of Vistor at the end of 2020. He holds a M.Sc. degree in Brand and Communications Management from Copenhagen Business School and a Bachelor's Degree in Economics from Auburn Montgomery. Prior to his role as General Manager Mr. Þórðarson was Marketing Manager at Vistor since 2018 and prior to that he worked at Novo Nordisk, both as Global Product Manager and Brand Manager in the headquarters, as well as in German and Danish subsidiaries of the company.

Board of directors

Thoranna Jonsdottir

Chairman of the Board of Vistor

Thoranna has recently worked as independent management consultant, e.g. for Alvotech, Marel and several public institutions. She has served in various positions at Reykjavik University, served as dean of the Department of Business from 2013-2016 and prior to that as senior executive director of strategy and operations. Thoranna served as Business Development Officer at the sister companies Veritas and Vistor in 2005-2008, she was the first General Manager of Artasan and one of the founders of Audur Capital. Thoranna has extensive experience of board membership, she is Chairman of the Board of Landsbref, a member of the board of Veritas since 2018 and prior to that, among others, served on the boards of, Krónan, Íslandsbanki and Lyfja. Thoranna holds a doctorate in business from Cranfield University, an MBA degree from IESE in Barcelona and a master´s degree in pharmaceuticals.

Guðbjörg Alfreðsdóttir

Board member

Mrs. Alfredsdottir has over 30 years of experience of pharmaceutical sales and marketing, of which she has been in leadership positions for over 20 years. She started working at Pharmaco, that later became Vistor, in 1977. From 2008-2012 she held the position of General Manager at Vistor. Throughout the years she has represented the pharmaceutical industry in various tasks where she has either been appointed by the industry or the Government. Mrs. Alfredsdottir was appointed by the Minister of Health to represent the industry on a committee with the task of developing future pharmaceutical strategy for Iceland. The committee completed the task in 2007. Mrs. Alfredsdottir holds a Master's degree in Pharmacy from the University of Iceland and the Royal School of Pharmacy in Copenhagen. She also finished an AMP program at INSEAD in 2007 as well as FUAMP at INSEAD in 2010.

Ingólf­ur Örn Guðmunds­son

Board member

Ingolf­ur Orn Gudmunds­son holds a B.Sc. degree in Product Design from Ohio State University, an MBA degree from the University of Iceland, as well as having finished studies in PMD (Project Management in Development) from the University of Reykjavik. Ingolfur has worked in the international environment of marketing for over 25 years. Mostly he worked at Mar­el (a global leader in transforming the way food is processed), first as product designer within the field of product development and for more than 22 years he led the international marketing build-up at Marel. In addition, he has had various tasks in the field of product development, strategic planning and sales. In 2018 Ingólf­ur changed to another line of business and built up marketing at the innovation company Kerecis (pioneering the use of fish skin and fatty acids in the globally expanding cellular-therapy and regenerative-medicine markets). After that he worked for a while as Business Development Manager at Skaginn 3X (fish and meat processing systems for the food industry), before starting to work as independent entrepreneur in the field of marketing.